ANI Pharmaceuticals, Inc. (ANIP) vs Supernus Pharmaceuticals, Inc. (SUPN)

ANI Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Supernus Pharmaceuticals, Inc. is the larger, with a market value of $2.5B against $1.7B — 1.5× the size. Supernus Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; ANI Pharmaceuticals, Inc. trades at 15.3×. ANI Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 30.9% against 24.9%. ANI Pharmaceuticals, Inc. has the higher net margin (11.0% vs −13.2%) and the higher return on invested capital (11.3% vs −12.4%). Across the 19 metrics below, ANI Pharmaceuticals, Inc. leads on 15 and Supernus Pharmaceuticals, Inc. on 4.